Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2025 · 10-Q
Revenue$10.86B$10.86B+3.0% vs Q2 2024 Net Income$1.62B$1.62B+4.5% vs Q2 2024 EPS Diluted$4.28$4.28+5.9% vs Q2 2024 Operating Income$1,834,000,000+0.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,105,000,000−33.4% Margins · derivedOperating margin16.9%−0.4 pt vs Q2 2024
Net margin14.9%+0.2 pt vs Q2 2024
ended Jun 28, 2025 · filed Aug 1, 2025 · 34 d after period end